PubMed (GeneRIF) for id: 429

Year	Number of Results
2002	1
2003	3
2004	2
2005	4
2006	1
2007	1
2008	8
2009	4
2010	9
2011	5
2012	5
2013	7
2014	4
2015	4
2016	4
2017	6
2018	2
2019	6
2020	9
2021	4
2022	8
2023	6
2024	1

1

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene.

Malbos M, Wakeling E, Gautier T, Boespflug-Tanguy O, Busby L, Taylor-Miller T, Dudoignon B, Bokov P, Govin J, Grisval M, Rega A, Mourot De Rougemont MG, Aubriot-Lorton MH, Darmency V, Bensignor C, Houzel A, Huet F, Denommé-Pichon AS, Delanne J, Tran Mau-Them F, Bruel AL, Safraou H, Nambot S, Garde A, Philippe C, Duffourd Y, Vitobello A, Faivre L, Thauvin-Robinet C. Malbos M, et al. Clin Genet. 2024 May;105(5):555-560. doi: 10.1111/cge.14485. Epub 2024 Jan 29. Clin Genet. 2024. PMID: 38287449

2

ASCL1 induces neurogenesis in human Müller glia.

Wohlschlegel J, Finkbeiner C, Hoffer D, Kierney F, Prieve A, Murry AD, Haugan AK, Ortuño-Lizarán I, Rieke F, Golden SA, Reh TA. Wohlschlegel J, et al. Stem Cell Reports. 2023 Dec 12;18(12):2400-2417. doi: 10.1016/j.stemcr.2023.10.021. Epub 2023 Nov 30. Stem Cell Reports. 2023. PMID: 38039971 Free PMC article.

3

ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity.

Abashkin DA, Karpov DS, Kurishev AO, Marilovtseva EV, Golimbet VE. Abashkin DA, et al. Int J Mol Sci. 2023 Oct 30;24(21):15746. doi: 10.3390/ijms242115746. Int J Mol Sci. 2023. PMID: 37958729 Free PMC article.

4

Ubiquitination of ASCL1 mediates CD47 transcriptional activation of the AKT signaling pathway, and glycolysis promotes osteogenic differentiation of hBMSCs.

Zhang J, Zhu L, Zhou J, Yu Q, Yang G, Zhao K, Luo C, Meng J, Liu J, Yang X. Zhang J, et al. In Vitro Cell Dev Biol Anim. 2023 Sep;59(8):636-648. doi: 10.1007/s11626-023-00811-0. Epub 2023 Oct 2. In Vitro Cell Dev Biol Anim. 2023. PMID: 37783914 Free PMC article.

5

ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.

Tabrizian N, Nouruzi S, Cui CJ, Kobelev M, Namekawa T, Lodhia I, Talal A, Sivak O, Ganguli D, Zoubeidi A. Tabrizian N, et al. Cell Rep. 2023 Aug 29;42(8):112937. doi: 10.1016/j.celrep.2023.112937. Epub 2023 Aug 7. Cell Rep. 2023. PMID: 37552603 Free article.

6

An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.

Horie M, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E, Miyashita N, Saito A, Nakatani Y, Yachida S. Horie M, et al. Cancer Sci. 2023 Jun;114(6):2596-2608. doi: 10.1111/cas.15764. Epub 2023 Mar 15. Cancer Sci. 2023. PMID: 36840413 Free PMC article.

7

Validation of ASCL1 and LHX8 Methylation Analysis as Primary Cervical Cancer Screening Strategy in South African Women with Human Immunodeficiency Virus.

Vink FJ, Meijer CJLM, Lissenberg-Witte BI, Visser C, Duin S, Snyman LC, Richter KL, van der Merwe FH, Botha MH, Steenbergen RDM, Dreyer G. Vink FJ, et al. Clin Infect Dis. 2023 Feb 8;76(3):416-423. doi: 10.1093/cid/ciac801. Clin Infect Dis. 2023. PMID: 36366827 Free PMC article.

8

ASCL1 regulates super-enhancer-associated miRNAs to define molecular subtypes of small cell lung cancer.

Miyakawa K, Miyashita N, Horie M, Terasaki Y, Tanaka H, Urushiyama H, Fukuda K, Okabe Y, Ishii T, Kuwahara N, Suzuki HI, Nagase T, Saito A. Miyakawa K, et al. Cancer Sci. 2022 Nov;113(11):3932-3946. doi: 10.1111/cas.15481. Epub 2022 Aug 30. Cancer Sci. 2022. PMID: 35789143 Free PMC article.

9

ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.

Nouruzi S, Ganguli D, Tabrizian N, Kobelev M, Sivak O, Namekawa T, Thaper D, Baca SC, Freedman ML, Aguda A, Davies A, Zoubeidi A. Nouruzi S, et al. Nat Commun. 2022 Apr 27;13(1):2282. doi: 10.1038/s41467-022-29963-5. Nat Commun. 2022. PMID: 35477723 Free PMC article.

10

REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.

Masawa M, Sato-Yazawa H, Kashiwagi K, Ishii J, Miyata-Hiramatsu C, Iwamoto M, Kohno K, Miyazawa T, Onozaki M, Noda S, Shimizu Y, Niho S, Yazawa T. Masawa M, et al. Am J Pathol. 2022 Jun;192(6):847-861. doi: 10.1016/j.ajpath.2022.03.007. Epub 2022 Mar 30. Am J Pathol. 2022. PMID: 35367201 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

93 results

Results by year